AI Article Synopsis
- The study assessed the safety and effectiveness of a specific prostate surgery (photoselective vaporization) for treating benign prostatic hyperplasia (BPH) in 229 patients over four years.
- The patients, mainly around 71 years old, experienced significant improvements in symptoms and urine flow shortly after the surgery, with a noticeable reduction in prostate size and issues like postvoid residual urine.
- The results indicated that this surgical method is generally safe, with minimal complications, and maintained positive outcomes for up to two years post-operation.
Article Abstract
Purpose: This study evaluated the safety and efficacy of photoselective vaporization of prostate using the 120 W High Performance System for management of symptomatic benign prostatic hyperplasia (BPH).
Methods: We prospectively obtained data from 229 patients between January 2009 and December 2012. We evaluated the serum prostate specific antigen level, International Prostate Symptom Score (IPSS), prostate volume; maximum urine flow rate (Q); and postvoid residual urine volume (PVR) in the patients at presentation and on follow-up at 1, 6, 12, and 24 months. The mean duration of the surgery, energy used, hospital stay, and intra- and postoperative complications were assessed.
Results: The mean age of the patients was 71.2 ± 9.6 years, and the mean preoperative size of the prostate was 59.41 ± 28.1 mL. The mean duration of the surgery was 47.35 ± 16.14 min, and the mean energy use was 184.39 ± 101.3 kJ. The mean time to removal of the urinary catheter was 21.45 ± 11.06 h, while the mean duration of hospital stay was 24.82 ± 11.5 h. The IPSS declined and mean Q increased by over twofold within the first month. The PVR also declined significantly in all groups up to 6 months after the surgery and increased slightly thereafter. Urinary urgency and incontinence occurred in two patients, while four patients developed urinary strictures. Between 12 and 24 months after the surgery, four patients underwent repeat surgery.
Conclusions: Our findings show that photoselective vaporization is safe and effective for the management of BPH and resulted in few complications. It yielded improvements in all parameters that were sustained even up to 2 years after the surgery.
Download full-text PDF |
Source |
|---|---|
| http://dx.doi.org/10.1089/pho.2016.4237 | DOI Listing |
Publication Analysis
Top Keywords
Similar Publications
Letter to the editor: anticoagulation, photoselective vaporization of the prostate and safety: a propensity score-matched study.
World J Urol
December 2024
School of Pharmacy, Hubei University of Traditional Chinese Medicine, Wuhan, 430065, China.
Impact of Obesity on Clinical Presentation and Surgical Outcomes in Patients with Benign Prostate Hyperplasia Receiving Greenlight Laser Prostatectomy.
Clin Interv Aging
December 2024
Division of Urology, Department of Surgery, Chang Gung Memorial Hospital, Linkou Branch, Taoyuan City, Taiwan.
Objective: To investigate the impact of body mass index (BMI) on preoperative characteristics, lower urinary tract symptoms (LUTS), intraoperative variables, surgical outcomes and postoperative complications.
Methods: This is a retrospective observational study including 891 benign prostate hyperplasia (BPH) patients who underwent GreenLight Laser photoselective vaporization of the prostate (PVP) between 2014 and 2020. Clinical characteristics, uroflowmetry parameters, and surgery related parameters were extracted from electronic health records.
A 72-year-old high-risk male presented to our hospital with severe bladder outlet obstruction (BOO) caused by an enlarged prostate with a volume exceeding 130 cc. Subsequently, the patient successfully underwent GreenLight laser (Boston Scientific, Marlborough, MA, USA) photoselective vaporization of the prostate (PVP). The patient had been unsuitable for conventional surgical modalities such as transurethral resection of the prostate (TURP) or open prostatectomy due to multiple pre-existing comorbidities, including coronary artery disease (CAD), atrial fibrillation (AF), and concurrent use of antiplatelet therapy.
View Article and Find Full Text PDFObjective Our study was designed to evaluate the postoperative urinary retention (UR) and success rate of the GreenLight Laser (Boston Scientific, Marlborough, MA, USA) photoselective vaporization of the prostate (GLL.PVP) procedure for Benign Prostatic Hyperplasia (BPH) patients, both with and without high-risk factors. Methodology We conducted a retrospective follow-up study of postoperative patients who underwent GLL.
View Article and Find Full Text PDFAnticoagulation, photoselective vaporization of the prostate and safety : a propensity score-matched study.
World J Urol
November 2024
Urology Department, University Hospital Center of Besançon, 3, Boulevard Fleming, Besançon, 25000, France.
Purpose: We compared surgical complications after laser prostatic photovaporization in anticoagulated versus non-anticoagulated patients.
Methods: A propensity score was calculated and patients were matched, to compare postoperative complications using the Clavien-Dindo classification between the anticoagulated and non-anticoagulated groups. We also identified factors associated with complications, and perform an analysis of secondary endpoint with categories of urological complications.
Want AI Summaries of new PubMed Abstracts delivered to your In-box?
Enter search terms and have AI summaries delivered each week - change queries or unsubscribe any time!